 | • レポートコード：GIR201115766 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ラコサミドの世界市場を調査対象にし、ラコサミドの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口錠剤、経口液剤、静脈内）、用途別分析（成人、小児患者）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：UCB、Accord Healthcare、MSN Laboratories、Teva、Aurobindo Pharma、Amneal Pharmaceuticals、Sun Pharma、Glenmark、Alembic Pharma、Mylan、Apotex ・企業別売上、市場シェア ・ラコサミドの地域別市場分析 ・ラコサミドの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ラコサミドのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ラコサミドのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ラコサミドの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ラコサミドの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ラコサミドの種類別市場規模2015-2020：経口錠剤、経口液剤、静脈内 ・ラコサミドの用途別市場規模2015-2020：成人、小児患者 ・ラコサミドの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Lacosamide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lacosamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lacosamide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lacosamide market has been segmented into:
Oral tablets
Oral solution
Intravenous
By Application, Lacosamide has been segmented into:
Adults
Pediatric patients
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lacosamide market presented in the report. This section sheds light on the sales growth of different regional and country-level Lacosamide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lacosamide market.
The report offers in-depth assessment of the growth and other aspects of the Lacosamide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Lacosamide Market Share Analysis
Lacosamide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lacosamide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lacosamide sales, revenue and market share for each player covered in this report.
The major players covered in Lacosamide are:
UCB
Accord Healthcare
MSN Laboratories
Teva
Aurobindo Pharma
Amneal Pharmaceuticals
Sun Pharma
Glenmark
Alembic Pharma
Mylan
Apotex
1 Lacosamide Market Overview
1.1 Product Overview and Scope of Lacosamide
1.2 Classification of Lacosamide by Type
1.2.1 Global Lacosamide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lacosamide Revenue Market Share by Type in 2019
1.2.3 Oral tablets
1.2.4 Oral solution
1.2.5 Intravenous
1.3 Global Lacosamide Market by Application
1.3.1 Overview: Global Lacosamide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Lacosamide Market by Regions
1.4.1 Global Lacosamide Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lacosamide (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lacosamide Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lacosamide Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lacosamide Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lacosamide Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lacosamide Status and Prospect (2015-2025)
2 Company Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 UCB SWOT Analysis
2.1.4 UCB Product and Services
2.1.5 UCB Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.2 Accord Healthcare
2.2.1 Accord Healthcare Details
2.2.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Accord Healthcare SWOT Analysis
2.2.4 Accord Healthcare Product and Services
2.2.5 Accord Healthcare Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.3 MSN Laboratories
2.3.1 MSN Laboratories Details
2.3.2 MSN Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 MSN Laboratories SWOT Analysis
2.3.4 MSN Laboratories Product and Services
2.3.5 MSN Laboratories Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aurobindo Pharma
2.5.1 Aurobindo Pharma Details
2.5.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aurobindo Pharma SWOT Analysis
2.5.4 Aurobindo Pharma Product and Services
2.5.5 Aurobindo Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amneal Pharmaceuticals
2.6.1 Amneal Pharmaceuticals Details
2.6.2 Amneal Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amneal Pharmaceuticals SWOT Analysis
2.6.4 Amneal Pharmaceuticals Product and Services
2.6.5 Amneal Pharmaceuticals Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharma SWOT Analysis
2.7.4 Sun Pharma Product and Services
2.7.5 Sun Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.8 Glenmark
2.8.1 Glenmark Details
2.8.2 Glenmark Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Glenmark SWOT Analysis
2.8.4 Glenmark Product and Services
2.8.5 Glenmark Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.9 Alembic Pharma
2.9.1 Alembic Pharma Details
2.9.2 Alembic Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Alembic Pharma SWOT Analysis
2.9.4 Alembic Pharma Product and Services
2.9.5 Alembic Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mylan SWOT Analysis
2.10.4 Mylan Product and Services
2.10.5 Mylan Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apotex SWOT Analysis
2.11.4 Apotex Product and Services
2.11.5 Apotex Lacosamide Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lacosamide Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lacosamide Players Market Share
3.2.2 Top 10 Lacosamide Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lacosamide Revenue and Market Share by Regions
4.2 North America Lacosamide Revenue and Growth Rate (2015-2020)
4.3 Europe Lacosamide Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lacosamide Revenue and Growth Rate (2015-2020)
4.5 South America Lacosamide Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lacosamide Revenue and Growth Rate (2015-2020)
5 North America Lacosamide Revenue by Countries
5.1 North America Lacosamide Revenue by Countries (2015-2020)
5.2 USA Lacosamide Revenue and Growth Rate (2015-2020)
5.3 Canada Lacosamide Revenue and Growth Rate (2015-2020)
5.4 Mexico Lacosamide Revenue and Growth Rate (2015-2020)
6 Europe Lacosamide Revenue by Countries
6.1 Europe Lacosamide Revenue by Countries (2015-2020)
6.2 Germany Lacosamide Revenue and Growth Rate (2015-2020)
6.3 UK Lacosamide Revenue and Growth Rate (2015-2020)
6.4 France Lacosamide Revenue and Growth Rate (2015-2020)
6.5 Russia Lacosamide Revenue and Growth Rate (2015-2020)
6.6 Italy Lacosamide Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lacosamide Revenue by Countries
7.1 Asia-Pacific Lacosamide Revenue by Countries (2015-2020)
7.2 China Lacosamide Revenue and Growth Rate (2015-2020)
7.3 Japan Lacosamide Revenue and Growth Rate (2015-2020)
7.4 Korea Lacosamide Revenue and Growth Rate (2015-2020)
7.5 India Lacosamide Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lacosamide Revenue and Growth Rate (2015-2020)
8 South America Lacosamide Revenue by Countries
8.1 South America Lacosamide Revenue by Countries (2015-2020)
8.2 Brazil Lacosamide Revenue and Growth Rate (2015-2020)
8.3 Argentina Lacosamide Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lacosamide by Countries
9.1 Middle East & Africa Lacosamide Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lacosamide Revenue and Growth Rate (2015-2020)
9.3 UAE Lacosamide Revenue and Growth Rate (2015-2020)
9.4 Egypt Lacosamide Revenue and Growth Rate (2015-2020)
9.5 South Africa Lacosamide Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lacosamide Revenue and Market Share by Type (2015-2020)
10.2 Global Lacosamide Market Forecast by Type (2019-2024)
10.3 Oral tablets Revenue Growth Rate (2015-2025)
10.4 Oral solution Revenue Growth Rate (2015-2025)
10.5 Intravenous Revenue Growth Rate (2015-2025)
11 Global Lacosamide Market Segment by Application
11.1 Global Lacosamide Revenue Market Share by Application (2015-2020)
11.2 Lacosamide Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2015-2020)
11.4 Pediatric patients Revenue Growth (2015-2020)
12 Global Lacosamide Market Size Forecast (2021-2025)
12.1 Global Lacosamide Market Size Forecast (2021-2025)
12.2 Global Lacosamide Market Forecast by Regions (2021-2025)
12.3 North America Lacosamide Revenue Market Forecast (2021-2025)
12.4 Europe Lacosamide Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lacosamide Revenue Market Forecast (2021-2025)
12.6 South America Lacosamide Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lacosamide Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Lacosamide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lacosamide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lacosamide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lacosamide Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. UCB Corporate Information, Location and Competitors
Table 6. UCB Lacosamide Major Business
Table 7. UCB Lacosamide Total Revenue (USD Million) (2017-2018)
Table 8. UCB SWOT Analysis
Table 9. UCB Lacosamide Product and Solutions
Table 10. UCB Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Accord Healthcare Corporate Information, Location and Competitors
Table 12. Accord Healthcare Lacosamide Major Business
Table 13. Accord Healthcare Lacosamide Total Revenue (USD Million) (2018-2019)
Table 14. Accord Healthcare SWOT Analysis
Table 15. Accord Healthcare Lacosamide Product and Solutions
Table 16. Accord Healthcare Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. MSN Laboratories Corporate Information, Location and Competitors
Table 18. MSN Laboratories Lacosamide Major Business
Table 19. MSN Laboratories Lacosamide Total Revenue (USD Million) (2017-2018)
Table 20. MSN Laboratories SWOT Analysis
Table 21. MSN Laboratories Lacosamide Product and Solutions
Table 22. MSN Laboratories Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Teva Corporate Information, Location and Competitors
Table 24. Teva Lacosamide Major Business
Table 25. Teva Lacosamide Total Revenue (USD Million) (2017-2018)
Table 26. Teva SWOT Analysis
Table 27. Teva Lacosamide Product and Solutions
Table 28. Teva Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Aurobindo Pharma Corporate Information, Location and Competitors
Table 30. Aurobindo Pharma Lacosamide Major Business
Table 31. Aurobindo Pharma Lacosamide Total Revenue (USD Million) (2017-2018)
Table 32. Aurobindo Pharma SWOT Analysis
Table 33. Aurobindo Pharma Lacosamide Product and Solutions
Table 34. Aurobindo Pharma Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Amneal Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Amneal Pharmaceuticals Lacosamide Major Business
Table 37. Amneal Pharmaceuticals Lacosamide Total Revenue (USD Million) (2017-2018)
Table 38. Amneal Pharmaceuticals SWOT Analysis
Table 39. Amneal Pharmaceuticals Lacosamide Product and Solutions
Table 40. Amneal Pharmaceuticals Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sun Pharma Corporate Information, Location and Competitors
Table 42. Sun Pharma Lacosamide Major Business
Table 43. Sun Pharma Lacosamide Total Revenue (USD Million) (2017-2018)
Table 44. Sun Pharma SWOT Analysis
Table 45. Sun Pharma Lacosamide Product and Solutions
Table 46. Sun Pharma Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Glenmark Corporate Information, Location and Competitors
Table 48. Glenmark Lacosamide Major Business
Table 49. Glenmark Lacosamide Total Revenue (USD Million) (2017-2018)
Table 50. Glenmark SWOT Analysis
Table 51. Glenmark Lacosamide Product and Solutions
Table 52. Glenmark Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Alembic Pharma Corporate Information, Location and Competitors
Table 54. Alembic Pharma Lacosamide Major Business
Table 55. Alembic Pharma Lacosamide Total Revenue (USD Million) (2017-2018)
Table 56. Alembic Pharma SWOT Analysis
Table 57. Alembic Pharma Lacosamide Product and Solutions
Table 58. Alembic Pharma Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Mylan Corporate Information, Location and Competitors
Table 60. Mylan Lacosamide Major Business
Table 61. Mylan Lacosamide Total Revenue (USD Million) (2017-2018)
Table 62. Mylan SWOT Analysis
Table 63. Mylan Lacosamide Product and Solutions
Table 64. Mylan Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Apotex Corporate Information, Location and Competitors
Table 66. Apotex Lacosamide Major Business
Table 67. Apotex Lacosamide Total Revenue (USD Million) (2017-2018)
Table 68. Apotex SWOT Analysis
Table 69. Apotex Lacosamide Product and Solutions
Table 70. Apotex Lacosamide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Lacosamide Revenue (Million USD) by Players (2015-2020)
Table 72. Global Lacosamide Revenue Share by Players (2015-2020)
Table 73. Global Lacosamide Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Lacosamide Revenue Market Share by Regions (2015-2020)
Table 75. North America Lacosamide Revenue by Countries (2015-2020)
Table 76. North America Lacosamide Revenue Market Share by Countries (2015-2020)
Table 77. Europe Lacosamide Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Lacosamide Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Lacosamide Revenue by Countries (2015-2020)
Table 80. South America Lacosamide Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Lacosamide Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Lacosamide Revenue Market Share by Countries (2015-2020)
Table 83. Global Lacosamide Revenue (Million USD) by Type (2015-2020)
Table 84. Global Lacosamide Revenue Share by Type (2015-2020)
Table 85. Global Lacosamide Revenue Forecast by Type (2021-2025)
Table 86. Global Lacosamide Revenue by Application (2015-2020)
Table 87. Global Lacosamide Revenue Share by Application (2015-2020)
Table 88. Global Lacosamide Revenue Forecast by Application (2021-2025)
Table 89. Global Lacosamide Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lacosamide Picture
Figure 2. Global Lacosamide Revenue Market Share by Type in 2019
Figure 3. Oral tablets Picture
Figure 4. Oral solution Picture
Figure 5. Intravenous Picture
Figure 6. Lacosamide Revenue Market Share by Application in 2019
Figure 7. Adults Picture
Figure 8. Pediatric patients Picture
Figure 9. Global Lacosamide Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Lacosamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Lacosamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Lacosamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Lacosamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Lacosamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Lacosamide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Lacosamide Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Lacosamide Revenue Market Share in 2019
Figure 18. Global Top 10 Players Lacosamide Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Lacosamide Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Lacosamide Revenue Market Share by Regions (2015-2020)
Figure 22. Global Lacosamide Revenue Market Share by Regions in 2018
Figure 23. North America Lacosamide Revenue and Growth Rate (2015-2020)
Figure 24. Europe Lacosamide Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Lacosamide Revenue and Growth Rate (2015-2020)
Figure 26. South America Lacosamide Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Lacosamide Revenue and Growth Rate (2015-2020)
Figure 28. North America Lacosamide Revenue Market Share by Countries (2015-2020)
Figure 29. North America Lacosamide Revenue Market Share by Countries in 2019
Figure 30. USA Lacosamide Revenue and Growth Rate (2015-2020)
Figure 31. Canada Lacosamide Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Lacosamide Revenue and Growth Rate (2015-2020)
Figure 33. Europe Lacosamide Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Lacosamide Revenue Market Share by Countries in 2019
Figure 35. Germany Lacosamide Revenue and Growth Rate (2015-2020)
Figure 36. UK Lacosamide Revenue and Growth Rate (2015-2020)
Figure 37. France Lacosamide Revenue and Growth Rate (2015-2020)
Figure 38. Russia Lacosamide Revenue and Growth Rate (2015-2020)
Figure 39. Italy Lacosamide Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Lacosamide Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Lacosamide Revenue Market Share by Countries in 2019
Figure 42. China Lacosamide Revenue and Growth Rate (2015-2020)
Figure 43. Japan Lacosamide Revenue and Growth Rate (2015-2020)
Figure 44. Korea Lacosamide Revenue and Growth Rate (2015-2020)
Figure 45. India Lacosamide Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Lacosamide Revenue and Growth Rate (2015-2020)
Figure 47. South America Lacosamide Revenue Market Share by Countries (2015-2020)
Figure 48. South America Lacosamide Revenue Market Share by Countries in 2019
Figure 49. Brazil Lacosamide Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Lacosamide Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Lacosamide Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Lacosamide Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Lacosamide Revenue and Growth Rate (2015-2020)
Figure 54. UAE Lacosamide Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Lacosamide Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Lacosamide Revenue and Growth Rate (2015-2020)
Figure 57. Global Lacosamide Revenue Share by Type (2015-2020)
Figure 58. Global Lacosamide Revenue Share by Type in 2019
Figure 59. Global Lacosamide Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral tablets Revenue Growth Rate (2015-2020)
Figure 61. Global Oral solution Revenue Growth Rate (2015-2020)
Figure 62. Global Intravenous Revenue Growth Rate (2015-2020)
Figure 63. Global Lacosamide Revenue Share by Application (2015-2020)
Figure 64. Global Lacosamide Revenue Share by Application in 2019
Figure 65. Global Lacosamide Market Share Forecast by Application (2021-2025)
Figure 66. Global Adults Revenue Growth Rate (2015-2020)
Figure 67. Global Pediatric patients Revenue Growth Rate (2015-2020)
Figure 68. Global Lacosamide Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Lacosamide Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Lacosamide Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Lacosamide Revenue Market Forecast (2021-2025)
Figure 72. Europe Lacosamide Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Lacosamide Revenue Market Forecast (2021-2025)
Figure 74. South America Lacosamide Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Lacosamide Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
ルフィナミドの世界市場 2020年 Market Overview The global Rufinamide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rufinamide market report provides …- エトラビリンの世界市場 2020年 Market Overview The global Etravirine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Etravirine market report provides …
- タダラフィル経口の世界市場 2020年 Market Overview The global Tadalafil Oral market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tadalafil Oral market report p…
- 経口製剤用医薬品添加剤の世界市場 2020年 Market Overview The global Pharmaceutical Excipients for Oral Formulations market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- 医師処方口腔器具の世界市場 2020年 Market Overview The global Physician-prescribed Oral Appliances market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Physicia…